Qube Research & Technologies Ltd - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 127 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$3,971,901
+66.2%
155,456
+86.6%
0.01%
+11.1%
Q2 2023$2,389,417
+1092.5%
83,313
+605.2%
0.01%
+800.0%
Q4 2022$200,365
-49.0%
11,814
+1.7%
0.00%
-75.0%
Q2 2021$393,000
-21.4%
11,620
-4.0%
0.00%
-50.0%
Q1 2021$500,000
+31.2%
12,106
-56.9%
0.01%
-50.0%
Q1 2020$381,000
-48.2%
28,057
-58.6%
0.02%
-30.4%
Q4 2019$736,00067,7020.02%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2023
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 8,394$264,6630.19%
Global Wealth Strategies & Associates 100$3,1530.00%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders